| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 233.66B | 275.25B | 228.93B | 204.13B | 175.63B | 173.70B |
| Gross Profit | 57.74B | 64.12B | 55.92B | 48.99B | 32.76B | 22.04B |
| EBITDA | 30.47B | 34.77B | 30.38B | 25.42B | 13.98B | 8.86B |
| Net Income | 15.46B | 18.71B | 14.56B | 12.41B | 4.24B | 539.00M |
Balance Sheet | ||||||
| Total Assets | 303.62B | 316.65B | 301.47B | 270.92B | 272.31B | 241.72B |
| Cash, Cash Equivalents and Short-Term Investments | 20.63B | 29.96B | 25.68B | 31.81B | 56.03B | 37.94B |
| Total Debt | 160.82B | 120.22B | 149.24B | 138.60B | 153.93B | 136.17B |
| Total Liabilities | 202.51B | 171.12B | 202.10B | 184.31B | 197.72B | 171.13B |
| Stockholders Equity | 101.10B | 145.53B | 99.36B | 86.60B | 74.58B | 70.59B |
Cash Flow | ||||||
| Free Cash Flow | -7.88B | 7.86B | -12.54B | 1.19B | 3.11B | 15.13B |
| Operating Cash Flow | 2.48B | 50.92B | 29.45B | 24.08B | 7.75B | 25.72B |
| Investing Cash Flow | -11.01B | -44.48B | -43.68B | -31.53B | -6.65B | -16.73B |
| Financing Cash Flow | 3.47B | -2.17B | 8.20B | -16.79B | 16.98B | 4.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥21.77B | -49.82 | ― | 1.47% | 13.33% | 50.90% | |
66 Neutral | ¥225.17B | 10.97 | ― | 1.58% | 20.23% | 18.40% | |
63 Neutral | ¥112.39B | 5.71 | ― | 0.30% | 5.99% | 43.14% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥13.90B | 11.95 | ― | 0.55% | 16.33% | -38.51% | |
53 Neutral | ¥7.62B | -32.30 | 32.34% | ― | 13.13% | 1625.99% | |
53 Neutral | ¥119.79B | 43.10 | ― | 0.49% | 6.95% | 66.30% |